Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts

DSpace/Manakin Repository

Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts

Citable link to this page


Title: Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts
Author: Bisson, Gregory P.; Gross, Robert; Bellamy, Scarlett; Mogorosi, Mpho; Avalos, Ava; Friedman, Harvey; Dickinson, Diana; Ndwapi, Ndwapi; Gaolathe, Tendani; Rollins, Caitlin Kantrowitz; Frank, Ian

Note: Order does not necessarily reflect citation order of authors.

Citation: Bisson, Gregory P., Tendani Gaolathe, Robert Gross, Caitlin Rollins, Scarlett Bellamy, Mpho Mogorosi, Ava Avalos, et al. 2008. Overestimates of survival after HAART: implications for global scale-up efforts. PLoS ONE 3(3): e1725.
Full Text & Related Files:
Abstract: Background: Monitoring the effectiveness of global antiretroviral therapy scale-up efforts in resource-limited settings is a global health priority, but is complicated by high rates of losses to follow-up after treatment initiation. Determining definitive outcomes of these lost patients, and the effects of losses to follow-up on estimates of survival and risk factors for death after HAART, are key to monitoring the effectiveness of global HAART scale-up efforts. Methodology/Principal Findings: A cohort study comparing clinical outcomes and risk factors for death after HAART initiation as reported before and after tracing of patients lost to follow-up was conducted in Botswana's National Antiretroviral Therapy Program. 410 HIV-infected adults consecutively presenting for HAART were evaluated. The main outcome measures were death or loss to follow-up within the first year after HAART initiation. Of 68 patients initially categorized as lost, over half (58.8%) were confirmed dead after tracing. Patient tracing resulted in reporting of significantly lower survival rates when death was used as the outcome and losses to follow-up were censored [1-year Kaplan Meier survival estimate 0.92 (95% confidence interval, 0.88–0.94 before tracing and 0.83 (95% confidence interval, 0.79–0.86) after tracing, log rank P<0.001]. In addition, a significantly increased risk of death after HAART among men [adjusted hazard ratio 1.74 (95% confidence interval, 1.05–2.87)] would have been missed had patients not been traced [adjusted hazard ratio 1.41 (95% confidence interval, 0.65–3.05)]. Conclusions/Significance: Due to high rates of death among patients lost to follow-up after HAART, survival rates may be inaccurate and important risk factors for death may be missed if patients are not actively traced. Patient tracing and uniform reporting of outcomes after HAART are needed to enable accurate monitoring of global HAART scale-up efforts.
Published Version: doi:10.1371/journal.pone.0001725
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254493/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4596500
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search